Hospital/Health-System Pharmacy
Compounding after the meningitis tragedy: NCPA responds
MAY 15, 2013NCPA is working with healthcare leaders in Congress to ensure development of appropriate measures
MAY 15, 2013NCPA is working with healthcare leaders in Congress to ensure development of appropriate measures
Managed Medicaid captures almost half of fee-for-service Rxs, shifts patient care
MAY 15, 2013IMS study analyzes the shift from fee-for-service in four states through changes in prescriptions for antipsychotic drugs, diabetes therapies, and respiratory medications
MAY 15, 2013IMS study analyzes the shift from fee-for-service in four states through changes in prescriptions for antipsychotic drugs, diabetes therapies, and respiratory medications
Shining a light into the dark places
MAY 15, 2013When the U.S. Congress buries game-changing laws deep in the bowels of complicated acts named for other things altogether, you wonder why they can't just call things like they see 'em. For starters.
MAY 15, 2013When the U.S. Congress buries game-changing laws deep in the bowels of complicated acts named for other things altogether, you wonder why they can't just call things like they see 'em. For starters.
Apply sparingly to right ear until nurse stops shouting
MAY 15, 2013JP reaches down deep for his inner Dalai Lama
MAY 15, 2013JP reaches down deep for his inner Dalai Lama
FDA approves combination agent to help lower LDL cholesterol
MAY 06, 2013FDA has approved ezetimibe and atorvastatin (Liptruzet, Merck) tablets for the treatment of elevated low-density lipoprotein (LDL) cholesterol in patients with primary or mixed hyperlipidemia as adjunctive therapy to diet, according to the manufacturer.
MAY 06, 2013FDA has approved ezetimibe and atorvastatin (Liptruzet, Merck) tablets for the treatment of elevated low-density lipoprotein (LDL) cholesterol in patients with primary or mixed hyperlipidemia as adjunctive therapy to diet, according to the manufacturer.
Improved mental health seen with Medicaid coverage expansion
MAY 06, 2013Medicaid coverage was linked to “substantially reduced” depression and the increased diagnosis of diabetes and the use of diabetes medication among low-income adults. At the same time, Medicaid coverage had no detectable effect on the prevalence of diabetes, high cholesterol, or high blood pressure, according to the study published in the May 2 issue of The New England Journal of Medicine.
MAY 06, 2013Medicaid coverage was linked to “substantially reduced” depression and the increased diagnosis of diabetes and the use of diabetes medication among low-income adults. At the same time, Medicaid coverage had no detectable effect on the prevalence of diabetes, high cholesterol, or high blood pressure, according to the study published in the May 2 issue of The New England Journal of Medicine.
Better orthopedic surgery outcomes linked to epidural anesthesia
MAY 06, 2013The use of neuraxial, or epidural, anesthesia improved outcomes – including mortality – in patients undergoing hip and knee replacement surgery, according to a new study in the May issue of the journal Anesthesiology,
MAY 06, 2013The use of neuraxial, or epidural, anesthesia improved outcomes – including mortality – in patients undergoing hip and knee replacement surgery, according to a new study in the May issue of the journal Anesthesiology,
Asymptomatic C difficile carriers have risk factors at time of hospital admission
MAY 03, 2013Screening patients for risk factors upon hospital admission has potential to identify nearly three out of four asymptomatic carriers of Clostridium difficile, according to a new study published in the May issue of the American Journal of Infection Control.
MAY 03, 2013Screening patients for risk factors upon hospital admission has potential to identify nearly three out of four asymptomatic carriers of Clostridium difficile, according to a new study published in the May issue of the American Journal of Infection Control.
FDA limits use of tolvaptan; irreversible liver damage possible
APRIL 30, 2013
APRIL 30, 2013
By: FORMULARY STAFF
FDA has issued a Drug Safety Communication indicating that the drug tolvaptan (Samsca, Otsuka American Pharmaceuticals), used in the treatment of electrolyte disturbances, can cause irreversible liver injury with the potential to result in liver transplant or death.Valproate use during pregnancy increases risk of autism
APRIL 29, 2013Prenatal exposure to valproate significantly increased the risk of autism spectrum disorder and childhood autism in the offspring of mothers who took the anti-epileptic agent, according to a study published in the April 24 issue of the Journal of the American Medical Association.
APRIL 29, 2013Prenatal exposure to valproate significantly increased the risk of autism spectrum disorder and childhood autism in the offspring of mothers who took the anti-epileptic agent, according to a study published in the April 24 issue of the Journal of the American Medical Association.
